DIRECT BIOLOGICS LLC

In News

Exosomes Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com

Barchart.com - Feb 25, 2026

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

Rapid Micro Biosystems Receives Multi-System Order from Samsung Biologics to Expand Growth Direct Platform for Microbial Quality Control Automation - Quiver Quantitative

Quiver Quantitative - Mar 12, 2026

FibroBiologics (Nasdaq: FBLG) prices $1.7M direct sale and related $1.7M warrants - Stock Titan

Stock Titan - Dec 15, 2025

Direct Biologics Gets New Look in Noncompete, Trade Secrets Case - Bloomberg Law News

Bloomberg Law News - Apr 04, 2023

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - Newswire.com

Newswire.com - Jan 12, 2021

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics - The Pharma Letter

The Pharma Letter - Jun 30, 2024

Bankruptcy Law And Charging Order Law Collide Again In Pettine - Forbes

Forbes - Nov 23, 2023

Direct Biologics Reveals Successful Outcomes from EXIT COVID-19 Phase II Clinical Trial - PR Newswire UK

PR Newswire UK - Apr 06, 2022

Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer - citybiz

citybiz - Feb 15, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment